Illumina Ventures

Illumina Ventures is an independently managed venture fund in a strategic partnership with Illumina. Illumina provides the majority of their capital and access to the expertise and vision of the world's leading genomics solutions provider.

They invest primarily in early stage companies, in areas where their expertise and special relationship with Illumina can add value. They typically syndicate with other leading institutional and strategic investors.

Focus areas include applications of genomics in life science research, healthcare, agriculture and environmental science, public safety and personal wellness.

Illumina Ventures, established in 2016 and headquartered in United States, North America., specializes in Late Stage Venture, Early Stage Venture, Seed investments across Biotechnology, Life Science, Genetics, Financial Services, Finance, Asset Management, Wealth Management, Retirement, Venture Capital, Consumer. The organization boasts a portfolio of 67 investments, with an average round size of $55.7M and 5 successful exits. Their recent investments include 23andMe, Fidelity, New Enterprise Associates, Google Ventures, Xfund. The highest investment round they participated in was $493.1B. Among their most notable exits are 23andMe and Fidelity. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.